메뉴 건너뛰기




Volumn 21, Issue 24, 2013, Pages 7988-7998

Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor

Author keywords

Binding mode; EGFR inhibitor; EGFR T790M L858R; Irreversible EGFR inhibitor

Indexed keywords

1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 1 [2 (DIETHYLAMINO)ETHYL] 1 METHYLUREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 1 [2 (DIMETHYLAMINO)ETHYL] 1 METHYLUREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 1 [3 (DIMETHYLAMINO)PROPYL] 1 METHYLUREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 (2 HYDROXYETHYL)UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 (2 METHOXYETHYL)UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 (3 METHOXYPROPYL)UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 (3 METHOXYROYL)UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 (3,3 DIMETHOXYPROPYL)UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [2 (DIETHYLAMINO)ETHYL]UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [2 (DIMETHYLAMINO)ETHYL]UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [2 (METHYLSULFONYL)ETHYL]UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [2 (MORPHOLINOETHYL)ETHYL]UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [2 (PIPERIDIN 1 YL)ETHYL]UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [2 (PYRROLIDIN 1 YL)ETHYL]UREA; 1 [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN3 YLOXY)QUINAZOLIN 6 YL] 3 [3,3 (DIMETHYLAMINO)PROPYL]UREA; 4 ANILINOQUINAZOLINE; ADENOSINE TRIPHOSPHATE; AFATINIB; CANERTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; LAPATINIB; N [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN 3 YLOXY)QUINAZOLIN 6 YL] 3 HYDROXYAZETIDINE 1 CARBOXAMIDE; N [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN 3 YLOXY)QUINAZOLIN 6 YL] 3,3 DIFLUOROPYRROLIDINE 1 CARBOXAMIDE; N [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN 3 YLOXY)QUINAZOLIN 6 YL] 4 FLUOROPIPERIDINE 1 CARBOXAMIDE; N [4 (3 CHLORO 4 FLUOROPHENYLAMINO) 7 (TETRAHYDROFURAN 3 YLOXY)QUINAZOLIN 6 YL] 4 METHYLPIPERAZINE 1 CARBOXAMIDE; NERATINIB; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84888440538     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2013.09.049     Document Type: Article
Times cited : (28)

References (37)
  • 36
    • 21744438303 scopus 로고    scopus 로고
    • Tripos: St. Louis, MO
    • sybyl, version 7.0, Tripos: St. Louis, MO, 2004.
    • (2004) Sybyl, Version 7.0


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.